Tech Company Financing Transactions
Archon Biosciences Funding Round
Archon Biosciences, based in Seattle, raised $20 million in funding from Madrona Venture Group, Alexandria Venture Investments and Cornucopian Capital.
Transaction Overview
Company Name
Announced On
10/30/2024
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its business reach.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1616 Eastlake Ave E 360
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Undisclosed
Website
Email Address
Overview
Archon Biosciences is a biotechnology company developing geometrically tunable protein therapeutics with differentiated distribution, engagement and function to target pathways other technologies cannot. This new biologic class, the Antibody Cage (AbC), was invented with the science and technology recognized by the 2024 Nobel Prize in Chemistry at the Baker Lab in the Institute for Protein Design (IPD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Technical Officer
George Ueda
Co-Founder
David Baker
Co-Founder
James Lazarovits
Co-Founder
Lance Stewart
VP - Bus. Development
Craig Halder
VP - R & D
Jon Graves
Browse more venture capital transactions:
Prev: 10/30/2024: Sana venture capital transaction
Next: 10/30/2024: Cornerstone AI venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs